Scientists from Cambridge have identified five distinct types of prostate cancer which they say will help in the fight against the disease.
The researchers from the Cancer Research UK institute in Cambridge say the findings could have important implications for how doctors treat the cancer in the future by identifying tumours that are more likely to grow and spread aggressively through the body.
The researchers, from the Cancer Research UK Cambridge Institute and Addenbrooke's Hospital, studied samples of healthy and cancerous prostate tissue from more than 250 men.
Study author Dr Alastair Lamb, from the Cancer Research UK Cambridge Institute, said:
More information on prostate cancer
A trend for posting 'no make-up selfies' is benefitting Cancer Research UK to the tune of £2 million. ,
The charity, which has its research centre in Cambridge, has seen an "unprecedented" increase in donations. The online campaign started a week ago, asking women to post selfies wearing no make-up, and men to wear as much as they like!!!
A six-year-old boy from Luton, who survived cancer and meningitis, has become one of just a few young ambassadors for Cancer Research UK.
Rhys Kiernan's brain tumour was removed successfully.
Despite still recovering, Rhys and his family have raised thousands of pounds for charity.
Olivia Paterson reports.
Scientists in Cambridge say they could be only five years away from delivering a routine test that tells us how likely we are to get common cancers.
It follows their discovery of more genetic causes of the disease.
And they hope that by understanding the causes of cancer better, they may get closer to discovering cures, as Elodie Harper reports.
Elodie Harper speaks to Cancer Research UK scientist Professor Doug Easton on what the new test for genetic risks of cancer could mean.
Research by Cambridge scientists could lead to routine tests for patients genetic risk of cancer within five years.
The study compared the DNA of more than 100,000 cancer patients with a similarly sized sample from the general population.
They used microchip technology capable of identifying more than 200,000 genetic variants, some of which were suspected of being linked to cancer.
More than 1,000 scientists from 130 institutions in Europe and the US took part in the Collaborative Oncological Gene-environment Study (Cogs).
Dr Harpal Kumar, chief executive of Cancer Research UK, which co-funded the research, said:
GPs could be routinely testing patients for genetic risk of cancer within five years following a landmark study by Cambridge scientists.
The biggest investigation of its kind ever carried out has greatly multiplied the number of known genetic markers linked to breast, prostate and ovarian cancer.
In future, the results may make it possible to single out individuals with a potentially lethal hand of genetic cards using a simple saliva test.
They can then be monitored closely for the first signs of developing cancer, or - in the most high risk cases - be offered preventative treatment.
Experts believe the cheap and easy tests could be conducted in family doctors' surgeries.
Samples would initially be sent off to laboratory specialists, but eventually GPs could be doing the analysis themselves.
As Cancer Research UK launches a campaign to raise awareness over the rising number of people getting cancer, we talk to former semi-professional footballer Lee Willcox from Ipswich about his battle with testicular cancer.